Notice of HY Results and Investor Presentation
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your SAR notes
Cambridge, UK, 20 March 2025 - Sareum Holdings plc (AIM: SAR), a biotechnology company developing next generation kinase inhibitors for autoimmune disease and cancer, will announce its unaudited half-year results for the six months ended 31 December 2024 on Tuesday, 25 March 2025.
On the same day at 14:00 GMT, the Company will be holding a live presentation to investors via the Investor Meet Company platform.
The presentation is open to all existing and potential shareholders. Questions can be submitted before the event via the Investor Meet Company dashboard up until 25 March 2025, 09:00 GMT, or at any time during the live presentation.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.